Statistical Aspects of the Design, Analysis, and Interpretation of Chronic Rodent Carcinogenicity Studies of Pharmaceuticals
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
May 8, 2001
January 26, 2021
f8ef1e83-587f-48eb-8b42-d6a9e1d3b934
Related Documents
Bioavailability and Bioequivalence Studies for Nasal Aerosols and Nasal Sprays for Local Action
Guidance DocumentApril 3, 2003Center for Drug Evaluation and Research
Evaluation of Therapeutic Equivalence
Guidance DocumentJuly 21, 2022Center for Drug Evaluation and Research
Pharmacokinetics in Pregnancy — Study Design, Data Analysis, and Impact on Dosing and Labeling
Guidance DocumentNovember 1, 2004Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.